Beam Therapeutics Inc. (BEAM) Stock Price

32.68 ▼ -3.14 (-8.77%)
Open: 35.64 Vol: 2.83M Day's range: 31.34 - 35.64 Jul 10, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BEAM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 32.82▼ 32.87▼ 32.81▼ 35.72▼ 33.09▼
MA10 32.86▼ 32.76▼ 33.69▼ 35.10▼ 31.67▲
MA20 32.89▼ 33.96▼ 35.21▼ 33.74▼ 29.25▲
MA50 32.84▼ 35.71▼ 35.24▼ 31.57▲ 26.39▲
MA100 33.48▼ 35.25▼ 35.06▼ 29.33▲ 24.78▲
MA200 35.14▼ 34.94▼ 32.86▼ 27.93▲ 28.44▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.020▼ -0.005▼ -0.392▼ -0.069▼ 0.403▲
RSI 39.763▼ 33.457▼ 33.564▼ 47.936▼ 55.980▲
STOCH 28.298     61.190     22.857     57.935     67.655    
WILL %R -100.000▼ -72.093     -80.079▼ -80.636▼ -37.652    
CCI -217.186▼ -23.469     -66.291     -140.468▼ 108.286▲
Latest Filters Detected On BEAM
RSI $BEAM RSI(14) Crossed Below 50 Set Alert
▼ MACD $BEAM MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $BEAM Price Crossed Below MA(26) Set Alert
MA $BEAM Price Crossed Below MA(13) Set Alert
MA $BEAM Price Crossed Below MA(7) Set Alert
▼ BREAK $BEAM Price Breaks 10 Days Low Set Alert
Beam Therapeutics Inc. News
Prime Medicine gains after winning arbitration with Beam Therapeutics
Wednesday, July 08, 2026 06:05 AM
Prime Medicine (PRME) stock jumps after an arbitration tribunal sides with the company in its dispute with Beam Therapeutics (BEAM). Read more here.
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
Friday, June 26, 2026 05:41 AM
Beam Therapeutics could have a moat around its business due to Risto-cel showing competitive efficacy. See why BEAM stock is downgraded to a hold.
Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug ...
Thursday, June 18, 2026 06:02 AM
BEAM-304 Development Approach Has Potential to Create Transformative, One-time Therapies for the Majority of Patients with PKU BEAM-304 Program Designed as Platform-based Approach Reflecting Emerging ...
BEAM historical stock data
date open high low close volume
10/07/26 35.64 35.64 31.34 32.68 2,825,418
09/07/26 36.63 37.78 35.315 35.82 2,503,629
08/07/26 36.434 37.435 35.00 36.88 3,925,721
07/07/26 36.50 38.26 34.4016 37.92 3,938,115
06/07/26 34.82 37.2999 33.73 35.32 2,402,876
02/07/26 33.82 35.74 33.635 34.79 2,262,024
01/07/26 34.406 35.81 32.84 33.48 2,135,906
30/06/26 34.83 36.06 33.6212 34.32 1,670,657
29/06/26 35.006 36.75 34.50 34.95 2,888,040
26/06/26 33.33 35.90 33.30 34.81 4,737,617
Quote Details
52wk Low:15.60
52wk High:38.26
Vol:2.83M
Avg Vol(3m):35.4M
1Y Chng:+56.89%
1M Chng:-0.37%
Add to Watch List
More Information
Index US Composite
Market Cap. 3.69B